Blood Collection From Individuals With Lung Disease for Genetic Studies

Completed

• Conditions: Lung Cancer; Asthma; Interstitial Lung Disease; Cystic Fibrosis; COPD

• Registration Number: NCT00362739
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

This is a research study where researchers are collecting blood to evaluate the genetic characteristics of individuals with chronic lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, cystic fibrosis, and lung cancer.

Detailed Description

The investigators hope to be able to identify an association between a genetic make-up in the blood samples and the risks of developing a particular lung disease, or severity of a lung disease. The findings of this study might be important to develop future preventative methods and potential treatments for the management of lung disease. The investigators aim to collect blood samples from 300 people with lung disease and 300 controls over 5 years.

Study Timeline

• Study Start: 2005-09
• Study First Submitted: 2006-08-08
• Study First Submitted QC: 2006-08-08
• Study First Posted: 2006-08-10
• Primary Completion: 2015-08
• Study Completion: 2015-08
• Status Verified: 2016-04
• Last Update Submitted: 2016-04-28
• Last Update Posted: 2016-04-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3087

Inclusion Criteria

• Must provide informed consent

• Males and females, age 18 years and older

• Lung disease proven by at least one of the following:

  • symptoms consistent with pulmonary disease
  • chest X-rays consistent with lung disease
  • pulmonary function tests consistent with lung disease
  • lung biopsy consistent with lung disease
  • family history of lung disease
  • disease of organs with know associated with lung disease
  • individuals suspected of history of lung disease based on history and/or physical examination
  • normal controls (individuals without history of lung disease) to be sampled to provide a comparison to the lung disease cohort.

Exclusion Criteria

• Drug and/or alcohol abuse within the past six months
• Females who are pregnant or nursing

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Establish a set of normal ranges for various parameters in healthy individual specimens and compare to specimens from individuals with lung disease to determine parameters resulting in disease susceptibility and severity.	5 years

Trial Locations

Locations (1)

New York Presbyterian Hospital -- Weill Cornell Medical College of Cornell University; 🇺🇸 New York, New York, United States